Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can drugs be designed?

R E Hubbard1

  • 1Department of Chemistry, University of York, Heslington, UK. rod@yorvic.york.ac.uk

Current Opinion in Biotechnology
|January 13, 1998
PubMed
Summary
This summary is machine-generated.

Rational drug design using structure-based methods, including NMR, shows promise. However, poor understanding of protein-ligand chemistry limits true drug design capabilities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using kidney transplantation to explore epigenetic markers of frailty.

GeroScience·2026
Same author

Important outcomes for patients with frailty admitted to hospital with peripheral arterial disease, their caregivers and their health professionals: A Nominal Group Technique study.

Geriatric nursing (New York, N.Y.)·2026
Same author

Frailty in younger adults in hospital.

QJM : monthly journal of the Association of Physicians·2023
Same author

Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals-a cluster randomised controlled trial.

Trials·2023
Same author

How frail is frail? A systematic scoping review and synthesis of high impact studies.

BMC geriatrics·2021
Same author

Frailty: A cost incurred by reproduction?

Scientific reports·2020
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Area of Science:

  • Medicinal Chemistry
  • Structural Biology
  • Drug Discovery

Background:

  • Rational, structure-based drug design methods are increasingly successful.
  • Nuclear Magnetic Resonance (NMR)-based techniques offer rapid routes for ligand design.
  • A significant limitation in drug design is the incomplete understanding of protein-ligand interactions.

Purpose of the Study:

  • To highlight the successes and limitations of current structure-based drug design approaches.
  • To emphasize the role of NMR in accelerating ligand design.
  • To identify the knowledge gap in protein-ligand interaction chemistry.

Main Methods:

  • Review of emerging examples in rational drug discovery.
  • Focus on innovative NMR-based methodologies for ligand design.

Related Experiment Videos

  • Analysis of the chemical principles governing protein-ligand binding.

    • Main Results:

    • Successful applications of structure-based drug design are accumulating.
    • NMR-based methods are proving effective for rapid ligand development.
    • Fundamental understanding of protein-ligand interaction chemistry remains a challenge.

    Conclusions:

    • Structure-based drug design, particularly with NMR, is advancing rapidly.
    • Improved understanding of protein-ligand chemistry is crucial for future drug design.
    • Further research into the chemistry of protein-ligand interactions is needed.